Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
| Current Price | ₹44.63 |
|---|---|
| Market Cap | ₹272 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > 0 |
| P/E Ratio | -247.9 |
| Return on Equity | -1.12% |
| 52-Week Range | ₹33.55 – ₹67.00 |
| Beta (1Y) | 1.02 |
1. Pharmaceuticals-100%
Zenotech Laboratories Ltd is trading at ₹44.63, with a market capitalisation of ₹272 Cr.
Zenotech Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > 0).
Zenotech Laboratories Ltd has a P/E of -247.9 and a return on equity of -1.12%.